Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults

American Journal of Respiratory and Critical Care Medicine

Volumn 183, Issue 7, 2011, Pages 891-897

  De Marco, Roberto ^a   Accordini, Simone ^a   Marcon, Alessandro ^a   Cerveri, Isa ^b   Antó, Josep M ^c,d,e,f   Gislason, Thorarinn ^g   Heinrich, Joachim ^h   Janson, Christer ⁱ   Jarvis, Deborah ^j   Kuenzli, Nino ^k,l   Leynaert, Bénédicte ^m   Sunyer, Jordi ^c,d,e,f   Svanes, Cecilie ^n,o   Wjst, Matthias ^h   Burney, Peter ^j  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^h INSTITUTE OF EPIDEMIOLOGY   (Germany)

ⁱ UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^j NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^k SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^l UNIVERSITY OF BASEL   (Switzerland)

^m INSERM   (France)

ⁿ UNIVERSITY OF BERGEN   (Norway)

^o HAUKELAND UNIVERSITY HOSPITAL   (Norway)

more..

Author keywords

Bronchial hyperreactivity; Chronic obstructive pulmonary disease; Epidemiology; Reference values; Risk factors

Indexed keywords

ADULT; AIRWAY CONSTRICTION; AIRWAY HYPERRESPONSIVENESS; ARTICLE; ASTHMA; CHILDHOOD; CHRONIC OBSTRUCTIVE LUNG DISEASE; FAMILY HISTORY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH SURVEY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; RISK FACTOR; SMOKING;

ADULT; AGE FACTORS; ASTHMA; BODY WEIGHT; BRONCHIAL HYPERREACTIVITY; CAUSALITY; COHORT STUDIES; COMORBIDITY; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MULTIVARIATE ANALYSIS; POISSON DISTRIBUTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RESPIRATORY TRACT INFECTIONS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SMOKING; YOUNG ADULT;

EID: 79953305304     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201007-1125OC     Document Type: Article

References (44)

1. Murray CJ, Lopez AD, Black R, Mathers CD, Shibuya K, Ezzati M, Salomon JA, Michaud CM, Walker N, Vos T. Global burden of disease 2005: call for collaborators. Lancet 2007;370:109-110.
2. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1:1645-1648. (Pubitemid 8124466)
3. de Marco R, Accordini S, Antò JM, Gislason T, Heinrich J, Janson C, Jarvis D, Künzli N, Leynaert B, Marcon A, et al. Long-term outcomes in mild/moderate chronic obstructive pulmonary disease in the European community respiratory health survey. Am J Respir Crit Care Med 2009;180:956-963.
4. Gould NS, Min E, Gauthier S, Chu HW, Martin R, Day BJ. Aging adversely affects the cigarette smoke induced glutathione adaptive response in the lung. Am J Respir Crit Care Med 2010;182:1114-1122.
5. Guerra S. Overlap of asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med 2005;11:7-13. (Pubitemid 40189245)
6. Weiss ST. What genes tell us about the pathogenesis of asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181:1170-1173.
7. Martinez FD. The origins of asthma and chronic obstructive pulmonary disease in early life. Proc Am Thorac Soc 2009;6:272-277.
8. Hnizdo E, Sullivan PA, Bang KM, Wagner G. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2002;156:7382746.
9. Torres-Duque C, Maldonado D, Perez-Padilla R, Ezzati M, Viegi G. Forum of International Respiratory Studies (FIRS) Task Force on Health Effects of Biomass Exposure. Biomass fuels and respiratory diseases: a review of the evidence. Proc Am Thorac Soc 2008;5:577-590.
10. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370:765-773. (Pubitemid 47321908)
11. de Marco R, Accordini S, Cerveri I, Corsico A, Antó JM, Künzli N, Janson C, Sunyer J, Jarvis D, Chinn S, et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med 2007;175:32-39. (Pubitemid 46105306)
12. de Marco R, Accordini S, Marcon A, Cerveri I, Corsico A, Anto J, Gulsvik A, Heinrich J, Janson C, Jarvis D, et al. Determinants of the 9-year incidence of COPD in an international cohort of young nonasthmatic adults. Preliminary results from ECRHS II [abstract]. Eur Respir J 2009;34:47s.
13. Burney PG, Luczynska C, Chinn S, Jarvis D. The European Community Respiratory Health Survey. Eur Respir J 1994;7:954-960. (Pubitemid 24153598)
14. European Community Respiratory Health Survey II Steering Committee. The European Community Respiratory Health Survey II. Eur Respir J 2002;20:1071-1079.
15. American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 1995;152:1107-1136.
16. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD [updated 2009; accessed 15 April 2010]. Available from: www.goldcopd.com
17. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5-40.
18. Kuster SP, Kuster D, Schindler C, Rochat MK, Braun J, Held L, Brändli O. Reference equations for lung function screening of healthy never-smoking adults aged 18-80 years. Eur Respir J 2008;31:860-868.
19. Greenland S, Drescher K. Maximum likelihood estimation of the attributable fraction from logistic models. Biometrics 1993;49:865-872. (Pubitemid 23298363)
20. Goldstein H. Multilevel statistical models, 3rd ed. London, UK: Edward Arnold; 2003.
21. Huber PJ. The behavior of maximum likelihood estimates under nonstandard conditions. In: Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability. Berkeley, CA: University of California Press; 1967; vol. 1: 221-33.
22. Wilson D, Adams R, Appleton S, Ruffin R. Difficulties identifying and targeting COPD and population-attributable risk of smoking for COPD: a population study. Chest 2005;128:2035-2042.
23. Pelkonen M. Smoking: relationship to chronic bronchitis, chronic obstructive pulmonary disease and mortality. Curr Opin Pulm Med 2008;14:105-109. (Pubitemid 351323160)
24. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009;360:2445-2454.
25. Rodríguez LAG, Wallander MA, Tolosa LB, Johansson S. Chronic obstructive pulmonary disease in UK primary care: incidence and risk factors. COPD 2009;6:369-379.
26. de Marco R. What evidence could validate the definition of COPD? Thorax 2008;63:756-757.
27. Orie NGM, Sluiter HJ, Vries K, Tammeling G, Witkop J. The host factor in bronchitis. In: Orie NGM, Sluiter HJ, editors. Bronchitis: an international symposium. Assen, the Netherlands: Royal van Gorcum; 1961:43-59.
28. Antó JM, Sunyer J, Basagaña X, Garcia-Esteban R, Cerveri I, de Marco R, Heinrich J, Janson C, Jarvis D, Kogevinas M, et al. Risk factors of new-onset asthma in adults: a population-based international cohort study. Allergy 2010;65:1021-1030.
29. Scichilone N, Battaglia S, La Sala A, Bellia V. Clinical implications of airway hyperresponsiveness in COPD. Int J Chron Obstruct Pulmon Dis 2006;1:49-60.
30. Svanes C, Sunyer J, Plana E, Dharmage S, Heinrich J, Jarvis D, de Marco R, Norbäck D, Raherison C, Villani S, et al. Early life origins of chronic obstructive pulmonary disease. Thorax 2010;65:14-20.
31. Brusselle GG. Matrix metalloproteinase 12, asthma, and COPD. N Engl J Med 2009;361:2664-2665.
32. de Marco R, Pattaro C, Locatelli F, Svanes C; ECRHS Study Group. Influence of early life exposures on incidence and remission of asthma throughout life. J Allergy Clin Immunol 2004;113:845-852. (Pubitemid 38608592)
33. van der Zalm MM, Uiterwaal CS, Wilbrink B, de Jong BM, Verheij TJ, Kimpen JL, van der Ent CK. Respiratory pathogens in respiratory tract illnesses during the first year of life: a birth cohort study. Pediatr Infect Dis J 2009;28:472-476.
34. Gualano RC, Vlahos R, Anderson GP. What is the contribution of respiratory viruses and lung proteases to airway remodelling in asthma and chronic obstructive pulmonary disease? Pulm Pharmacol Ther 2006;19:18-23.
35. Hogg JC. Childhood viral infection and the pathogenesis of asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 1999;160:S26-S28.
36. Løkke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax 2006;61:935-939. (Pubitemid 44787161)
37. Johannessen A, Omenaas E, Bakke P, Gulsvik A. Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. Int J Tuberc Lung Dis 2005;9:926-932. (Pubitemid 41139654)
38. Lindberg A, Eriksson B, Larsson LG, Rönmark E, Sandström T, Lundbäck B. Seven-year cumulative incidence of COPD in an age-stratified general population sample. Chest 2006;129:879-885.
39. van Durme YM, Verhamme KM, Stijnen T, van Rooij FJ, Van Pottelberge GR, Hofman A, Joos GF, Stricker BH, Brusselle GG. Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: the Rotterdam study. Chest 2009;135:368-377.
40. Probst-Hensch NM, Curjuric I, Pierre-Olivier B, Ackermann-Liebrich U, Bettschart RW, Brändli O, Brutsche M, Burdet L, Gerbase MW, Knöpfli B, et al. Longitudinal change of prebronchodilator spirometric obstruction and health outcomes: results from the SAPALDIA cohort. Thorax 2010;65:150-156.
41. Han MK, Postma D, Mannino DM, Giardino ND, Buist S, Curtis JL, Martinez FJ. Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med 2007;176:1179-1184. (Pubitemid 350256470)
42. Kirkpatrick P, Dransfield MT. Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment. Curr Opin Pulm Med 2009;15:100-104.
43. Guerra S, Sherrill DL, Bobadilla A, Martinez FD, Barbee RA. The relation of body mass index to asthma, chronic bronchitis, and emphysema. Chest 2002;122:1256-1263. (Pubitemid 35339538)
44. Götschi T, Sunyer J, Chinn S, de Marco R, Forsberg B, Gauderman JW, Garcia-Esteban R, Heinrich J, Jacquemin B, Jarvis D, et al. Air pollution and lung function in the European Community Respiratory Health Survey. Int J Epidemiol 2008;37:1349-1358.